Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures

J Dig Dis. 2024 Jan;25(1):2-13. doi: 10.1111/1751-2980.13248. Epub 2024 Feb 13.

Abstract

Endoscopy-guided endobiliary radiofrequency ablation has emerged as a novel treatment for malignant biliary strictures in recent years. When combined with biliary stenting and systemic chemotherapy, it can effectively postpone local tumor progression, improve patient's quality of life, and prolong their survival, which is mainly indicated for patients with inoperable extrahepatic cholangiocarcinoma and ampullary cancer. Based on the existing clinical evidence, the Digestive Endoscopology Branch of Chinese Medical Association, the Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association, and the National Clinical Research Center for Digestive Diseases (Shanghai) organized relevant experts to discuss the indications, contraindications, technical operation specifications, and prevention and treatment of the complications during endoscopy-guided endobiliary radiofrequency ablation. Consensus statements were established, trying to provide references for standard treatment of malignant biliary tumors in clinical practice.

Keywords: consensus; endoscopic retrograde cholangiopancreatography; malignant biliary stricture; radiofrequency ablation.

MeSH terms

  • Ampulla of Vater* / surgery
  • Bile Duct Neoplasms* / complications
  • Bile Duct Neoplasms* / surgery
  • Bile Ducts, Intrahepatic / surgery
  • Catheter Ablation* / adverse effects
  • China
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects
  • Cholestasis* / etiology
  • Common Bile Duct Neoplasms* / surgery
  • Constriction, Pathologic / etiology
  • Constriction, Pathologic / surgery
  • Endoscopy, Gastrointestinal
  • Humans
  • Quality of Life
  • Radiofrequency Ablation* / adverse effects
  • Stents / adverse effects
  • Treatment Outcome